Dr Amelia McCartney is a medical oncologist who obtained her medical degree from the University of Sydney in 2004. Prior to her medical studies, she graduated with a Bachelor of Science and a Bachelor of Arts from the Australian National University. She completed her specialist training in Victoria in centres including Epworth Freemasons, the Peter MacCallum Cancer Centre, University Hospital Geelong and Royal Melbourne Hospital.

She completed a four‐year fellowship in translational and clinical breast cancer research under the supervision and mentorship of Dr Angelo Di Leo in Prato, Italy. Dr McCartney’s areas of research interest are in the discovery and trialling of biomarkers related to prognosis and early response to treatment, mechanisms of treatment resistance, and strategies of safely de‐escalating breast cancer therapies. She returned to Australia in late 2020 to commence a public appointment at Monash Health. Dr McCartney’s research has been presented at international meetings including the American Society of Clinical Oncology (ASCO) Annual Meeting, the European Society for Medical Oncology (ESMO) Congress, the San Antonio Breast Cancer Symposium and the American Association for Cancer Research (AACR) Annual Meeting. She serves several international collaborative trial committees belonging to the International Breast Cancer Study Group (IBCSG) and the Breast International Group (BIG). Nationally she is a member of the Breast Cancer Trials Group (BCT), and is a current member of their scientific advisory committee. She is an adjunct clinical senior lecturer with Monash University.

Dr McCartney practices exclusively in breast cancer and joined the VBOC team in early 2024.

Google Scholar profile:
https://scholar.google.com/citations?hl=en&user=bEJm‐‐0AAAAJ

ORCID ID:
https://orcid.org/0000‐0003‐0411‐0736

ResearchGate profile:
https://www.researchgate.net/profile/Amelia_Mccartney